AM25-ST-20-L - CBC: Opportunities & Challenges the Field of Cord Blood and Birthing Tissues

Saturday, October 25, 2025

1:45 PM - 2:45 PM PT

Room: SDCC 32

Program Chair(s)

Frances Verter, PhD (she/her/hers)

CEO
Parent's Guide to Cord Blood Foundation
Brookeville, Maryland

Disclosure(s): No financial relationships to disclose
Joanne Kurtzberg, MD

Jerome Harris Distinguished Professor of Pediatrics Professor of Pathology Director, Marcus Center for Cellular Cures Director, Carolinas Cord Blood Bank Co-Director, Stem Cell Transplant Laboratory President, Cord Blood Association
Duke University
Durham, North Carolina

Disclosure information not submitted.

Speaker(s)

Frances Verter, PhD (she/her/hers)

CEO
Parent's Guide to Cord Blood Foundation
Brookeville, Maryland

Disclosure information not submitted.
Colleen Delaney, MD, MSc (she/her/hers)

VP and Chief Medical Officer; Interim Director; PI, Delaney Lab; Clinical Professor and Attending Physician, Stem Cell Transplant Service; Affiliate Investigator
Seattle Children’s Therapeutics (SCTx); Clinical Cell Processing Laboratory (CCPL); Seattle Children’s Research Institute (SCRI); University of WA, Dep’t of Pediatrics; Fred Hutch Cancer Center
seattle, Washington

Disclosure information not submitted.

Panelist(s)

Peter W. Marks, MD, PhD (he/him/his)

Independent Consultant
Pharmaceutical Industry
Washington, District of Columbia

Disclosure information not submitted.

Contemporary controversies and barriers have prevented the cord blood sector maximizing its full potential, in terms of impact on the lives of families and patients and in accelerating scientific innovation.

Learning Objectives:

Regulatory framework: how can we ensure continued patient safety and simultaneously maximize the impact of innovative therapies.
Unrealized therapeutic potential
Communication and miscommunication